The Board of Directors of Rainbow Children’s Medicare Limited, in their meeting held on January 28, 2026, approved the unaudited consolidated financial results for the quarter and nine months ended December 31, 2025. The company reported a consolidated revenue of ₹4,853.53 million for the quarter ended December 31, 2025, which is a 9.12% increase from ₹4,448.01 million in the previous quarter (Q2 FY26) and a 10.86% increase from ₹4,378.13 million in the corresponding quarter of the previous year (Q3 FY25). The consolidated profit after tax for the current quarter stood at ₹79.80 million, representing a 5.53% growth from ₹75.62 million in the previous quarter and a 5.51% increase compared to ₹75.63 million in the same period last year.
| Financial Metric (Consolidated) | Q3 FY26 (Current) | Q2 FY26 (Previous) | % Change (QoQ) | Q3 FY25 (Year-Ago) | % Change (YoY) |
| Revenue (₹ in Millions) | 4,853.53 | 4,448.01 | 9.12% | 4,378.13 | 10.86% |
| Profit After Tax (₹ in Millions) | 79.80 | 75.62 | 5.53% | 75.63 | 5.51% |
Rainbow Children’s Medicare Limited is India’s leading pediatric and perinatal healthcare network, operating 21 hospitals and 5 clinics across six key Indian cities as of 2025. Established in 1999, the group specializes in pediatrics, obstetrics, and gynecology, utilizing a hub-and-spoke model to provide comprehensive care ranging from secondary consultations to quaternary intensive care. In 2025, the company expanded its footprint by commencing a 100-bed greenfield hospital in Rajahmundry, Andhra Pradesh, and acquiring a 76% stake in Pratiksha Hospital to strengthen its Northeast operations. Notable institutional investors in the company include the Government of Singapore, Abu Dhabi Investment Authority, and various mutual funds such as DSP, Axis, and ICICI Prudential.
Leave a Reply